Global Lymphedema Treatment Market Size, Share, Forecast Report, 2020-2027

The global Lymphedema Treatment market garnered revenue around USD XX Billion in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of 4.4% throughout the estimate period from 2020 to 2027.

The increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market.

It is reported that a majority of the lymphedema cases affect cancer patients. The condition can arise immediately after cancer surgery or radiation therapy. However, in certain cases, lymphedema is reported after months or years of cancer treatment. Thus, it is projected that the global lymphedema treatment market will grow, parallelly, to the increasing prevalence of cancer

Increased research & development in the market is estimated to influence the commercialization in the market. The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Lymphedema Treatment market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Lymphedema Treatment market growth.

The global Lymphedema Treatment market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

3A Health Care (Italy)

Bio Compression Systems, Inc. (US)

Devon Medical Products (US)

HERANTIS PHARMA PLC (Finland)

Lohmann & Rauscher (Germany)

Mego Afek Ltd (US)

SIGVARIS (Switzerland)

Tactile Systems Technology Inc. (US)

Wright Therapy Products (BSN Medical) (Germany)

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Type

Primary Lymphedema is caused by the abnormal development of the lymph system. Symptoms may occur at birth or older age. The primary lymphedema segment is estimated to hold the least market share in 2018.

Secondary Lymphedema is caused by damage to the lymph system owing to cancer treatment involving surgery, radiation therapy, and others. A majority of the patients suffered from secondary lymphedema making this the leading segment in 2018.

By Affected Area

Lower Extremity: Lower extremity lymphedema involves the swelling of ankles, legs, and feet. This segment is estimated to hold a share of 0% in 2018.

Upper Extremity: Upper extremity lymphedema is one of the most poorly understood complications of the disease, making the segment to hold a share of 9.0% in the market in 2018.

Genitalia: This segment held the least share of the market in 2018.

By Treatment

Compression Devices & Bandaging: Compression devices are pumps connected to a sleeve that is then wrapped around the affected area that applies pressure. This helps the fluids to circulate through the lymph vessels and veins.

Bandaging involves wrapping, thereby helping in preventing the area from refilling with fluid. Lymphedema that has not improved with other treatments can be treated with bandaging. Thus, compression devices & bandaging segment was the largest segment of the lymphedema treatment market in 2018.

Laser Therapy: Laser therapy reduces lymphedema swelling after a mastectomy. The segment is estimated to be one of the fastest-growing segments.

Drug Therapy & Surgery: Drug therapy and surgery are the least opted treatment in the market, making the segment to hold the least share in the market.

By End-User

Hospitals and clinics: By the end, user, hospitals, and clinics holds the largest market share. Favorable government policies and rising awareness campaigns across the globe are responsible for increasing the number of patients seeking treatment through primary healthcare facilities, i.e., hospitals and clinics.

Clinical Research Organizations: A growing segment owing to an increasing number of upcoming treatments.

Research & Academic Institutes: Rapid technological advances and research & development collaborations are leading to significant growth by this segment.

Regional Analysis and Forecast



Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:



� North America

? U.S.

? Canada

� Europe

? Germany

? U.K.

? Italy

? France

? Rest of EU

� Asia Pacific

? China

? India

? Japan

? Southeast Asia

? Rest of APAC

� Central & South America

? Brazil

? Argentina

? Rest of Central & South America

� Middle East and Africa

? UAE

? Saudi Arabia

? Rest of MEA